Ocrevus 50242-0150-01

Generic: Ocrelizumab

Package NDC

50242-0150-01

Manufacturer: Genentech, Inc.
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: March 28, 2017
Listing Expires: December 31, 2027
Application: BLA761053

Need to source Ocrevus? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Ocrelizumab	300 mg/10mL

Drug Class

CD20-directed Cytolytic Antibody [EPC]AntibodiesMonoclonal [CS]

Selected Package

50242-0150-01Selected

1 VIAL, SINGLE-USE in 1 CARTON (50242-150-01) / 10 mL in 1 VIAL, SINGLE-USE